Abstract
There is little evidence regarding the efficacy and safety of bioresorbable scaffolds (BRS) for the percutaneous treatment ofchronic total occlusions (CTO). The aim of this study was to investigate the clinical outcomes of patients with a CTO treated with BRS or drug-eluting stents (DES). We
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have